Literature DB >> 1465285

Benign thyroid diseases and the risk of death from breast cancer.

M B Goldman1, R R Monson, F Maloof.   

Abstract

A survey of the causes of death among women with benign thyroid disease was conducted to assess the risk of breast cancer mortality in thyroid patients. The study population was all women diagnosed with one of several types of thyroid disease at the Massachusetts General Hospital Thyroid Clinic from 1925 to 1974. A population-based comparison group was matched to the Clinic patients for age and socioeconomic status, resulting in a total of 9,520 matched pairs. A search of the Massachusetts mortality records located death certificates for 10.9% (1,039) of the Thyroid Clinic patients and 10.5% (995) of the comparison women. Cancer was the cause of death in 21% (218) of the Thyroid Clinic patients and 24% (239) of the comparison women. Fewer patients than comparison women died from cancers of the digestive organs (30.2 vs. 45.5%), but more patients died from thyroid cancer (3.7 vs. 0%), lymphatic and hematopoietic cancers (11.5 vs. 4.2%), and cancers of other sites (8.3 vs. 3.8%). Breast cancer deaths accounted for 21.6% of cancer deaths in the patients and 22.2% of cancer deaths in the comparison women. When specific thyroid diagnoses were considered, the percent of all deaths due to breast cancer ranged from 1.9 to 5.6%, compared to 5.3% in the comparison women. Of the diagnostic groups studied, patients with Hashimoto's thyroiditis had the lowest percent of deaths due to breast cancer, while those with nontoxic nodular goiter had the highest.

Entities:  

Mesh:

Year:  1992        PMID: 1465285     DOI: 10.1159/000227093

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

1.  Autoimmune Thyroid Disease and Breast Cancer Prognosis.

Authors:  Tolga Özmen; Bahadır Mahmut Güllüoğlu; Cumhur Şevket Yegen; Atilla Soran
Journal:  J Breast Health       Date:  2015-04-01

2.  Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.

Authors:  C J Guigon; D W Kim; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

3.  Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells.

Authors:  M López-Barahona; I Fialka; J M González-Sancho; M Asunción; M González; T Iglesias; J Bernal; H Beug; A Muñoz
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

4.  Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women.

Authors:  Ada Tosovic; Anne-Greth Bondeson; Lennart Bondeson; Ulla-Britt Ericsson; Johan Malm; Jonas Manjer
Journal:  Breast Cancer Res       Date:  2010-06-11       Impact factor: 6.466

5.  Selected medical conditions and risk of breast cancer.

Authors:  R Talamini; S Franceschi; A Favero; E Negri; F Parazzini; C La Vecchia
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study.

Authors:  Chloe E Barr; Kelechi Njoku; Leo Hotchkies; Neil A J Ryan; Y Louise Wan; David A Davies; Salman Razvi; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2021-10-29       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.